Skip to content

Clinical trials

Phase 4 Generalized Anxiety Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Generalized Anxiety Disorder Phase: Phase 4 Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20043
20058
20064
20071
20084
20093
20103
20122
20131
20142
20152
20181
20192
20201
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Terminated4
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital5
University of Pennsylvania3
University of South Florida2
AbbVie1
Beth Israel Medical Center1
Creighton University1
Eli Lilly and Company1
Georgetown University1
H. Lundbeck A/S1
Marubeni Pharmaceuticals (Suzhou) Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Generalized Anxiety Disorder40
Anxiety Disorders26
Panic Disorder11
Phobia, Social5
Bipolar Disorder4
Major Depressive Disorder4
Agoraphobia2
Alcoholism2
Stress Disorders, Post-Traumatic2
Attention Deficit Disorder with Hyperactivity1

Trials

Showing 26 to 40 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.